Annual EBIT
-$20.56 M
-$6.72 M-48.53%
31 December 2023
Summary:
Eupraxia Pharmaceuticals Common Stock annual earnings before interest & taxes is currently -$20.56 million, with the most recent change of -$6.72 million (-48.53%) on 31 December 2023. During the last 3 years, it has fallen by -$18.97 million (-1193.81%). EPRX annual EBIT is now -1193.81% below its all-time high of -$1.50 million.EPRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$5.99 M
-$203.90 K-3.52%
01 September 2024
Summary:
Eupraxia Pharmaceuticals Common Stock quarterly earnings before interest & taxes is currently -$5.99 million, with the most recent change of -$203.90 thousand (-3.52%) on 01 September 2024. Over the past year, it has dropped by -$1.42 million (-30.93%). EPRX quarterly EBIT is now -4428.68% below its all-time high of $138.40 thousand, reached on 01 December 2020.EPRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$27.92 M
-$1.42 M-5.34%
01 September 2024
Summary:
Eupraxia Pharmaceuticals Common Stock TTM earnings before interest & taxes is currently -$27.92 million, with the most recent change of -$1.42 million (-5.34%) on 01 September 2024. Over the past year, it has dropped by -$2.34 million (-9.16%). EPRX TTM EBIT is now -2555.31% below its all-time high of -$1.05 million, reached on 01 September 2019.EPRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPRX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -48.5% | -30.9% | -9.2% |
| 3 y3 years | -1193.8% | -58.8% | -90.5% |
| 5 y5 years | -81.3% | -469.7% | -2555.3% |
EPRX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1193.8% | at low | -121.5% | +41.9% | -105.6% | +6.7% |
| 5 y | 5 years | -1193.8% | at low | -4428.7% | +41.9% | -2555.3% | +6.7% |
| alltime | all time | -1193.8% | at low | -4428.7% | +41.9% | -2555.3% | +6.7% |
Eupraxia Pharmaceuticals Common Stock EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.99 M(+3.5%) | -$27.92 M(+5.3%) |
| June 2024 | - | -$5.79 M(-0.8%) | -$26.51 M(-11.4%) |
| Mar 2024 | - | -$5.83 M(-43.5%) | -$29.93 M(+7.8%) |
| Dec 2023 | -$20.56 M(+48.5%) | -$10.31 M(+125.4%) | -$27.76 M(+8.5%) |
| Sept 2023 | - | -$4.58 M(-50.3%) | -$25.58 M(+3.6%) |
| June 2023 | - | -$9.20 M(+151.2%) | -$24.70 M(+23.0%) |
| Mar 2023 | - | -$3.66 M(-55.0%) | -$20.08 M(+4.8%) |
| Dec 2022 | -$13.84 M(-21.4%) | - | - |
| Dec 2022 | - | -$8.14 M(+120.4%) | -$19.16 M(+39.6%) |
| Sept 2022 | - | -$3.69 M(-19.5%) | -$13.73 M(-0.6%) |
| June 2022 | - | -$4.59 M(+67.2%) | -$13.81 M(+1.6%) |
| Mar 2022 | - | -$2.74 M(+1.4%) | -$13.58 M(-22.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$17.61 M(+1008.0%) | -$2.70 M(-28.3%) | -$17.50 M(+19.4%) |
| Sept 2021 | - | -$3.77 M(-13.6%) | -$14.66 M(+31.6%) |
| June 2021 | - | -$4.36 M(-34.5%) | -$11.14 M(+56.2%) |
| Mar 2021 | - | -$6.66 M(-4913.8%) | -$7.13 M(+346.9%) |
| Dec 2020 | -$1.59 M(-63.5%) | $138.40 K(-155.8%) | -$1.60 M(-17.5%) |
| Sept 2020 | - | -$248.20 K(-30.6%) | -$1.93 M(-29.3%) |
| June 2020 | - | -$357.70 K(-68.3%) | -$2.74 M(+15.0%) |
| Mar 2020 | - | -$1.13 M(+461.7%) | -$2.38 M(+90.1%) |
| Dec 2019 | -$4.35 M(-61.6%) | -$200.80 K(-80.9%) | -$1.25 M(+19.1%) |
| Sept 2019 | - | -$1.05 M | -$1.05 M |
| Dec 2018 | -$11.34 M(+197.1%) | - | - |
| Dec 2017 | -$3.82 M | - | - |
FAQ
- What is Eupraxia Pharmaceuticals Common Stock annual earnings before interest & taxes?
- What is the all time high annual EBIT for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock annual EBIT year-on-year change?
- What is Eupraxia Pharmaceuticals Common Stock quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock quarterly EBIT year-on-year change?
- What is Eupraxia Pharmaceuticals Common Stock TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock TTM EBIT year-on-year change?
What is Eupraxia Pharmaceuticals Common Stock annual earnings before interest & taxes?
The current annual EBIT of EPRX is -$20.56 M
What is the all time high annual EBIT for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high annual earnings before interest & taxes is -$1.50 M
What is Eupraxia Pharmaceuticals Common Stock annual EBIT year-on-year change?
Over the past year, EPRX annual earnings before interest & taxes has changed by -$6.72 M (-48.53%)
What is Eupraxia Pharmaceuticals Common Stock quarterly earnings before interest & taxes?
The current quarterly EBIT of EPRX is -$5.99 M
What is the all time high quarterly EBIT for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high quarterly earnings before interest & taxes is $138.40 K
What is Eupraxia Pharmaceuticals Common Stock quarterly EBIT year-on-year change?
Over the past year, EPRX quarterly earnings before interest & taxes has changed by -$1.42 M (-30.93%)
What is Eupraxia Pharmaceuticals Common Stock TTM earnings before interest & taxes?
The current TTM EBIT of EPRX is -$27.92 M
What is the all time high TTM EBIT for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high TTM earnings before interest & taxes is -$1.05 M
What is Eupraxia Pharmaceuticals Common Stock TTM EBIT year-on-year change?
Over the past year, EPRX TTM earnings before interest & taxes has changed by -$2.34 M (-9.16%)